These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32097030)

  • 1. Strategies to Reduce the Use of Gadolinium-Based Contrast Agents for Abdominal MRI in Children.
    Anderson MA; Harrington SG; Kozak BM; Gee MS
    AJR Am J Roentgenol; 2020 May; 214(5):1054-1064. PubMed ID: 32097030
    [No Abstract]   [Full Text] [Related]  

  • 2. Gadolinium-based contrast agents - review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients.
    Blumfield E; Swenson DW; Iyer RS; Stanescu AL
    Pediatr Radiol; 2019 Apr; 49(4):448-457. PubMed ID: 30923876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus Guidelines of the French Society of Neuroradiology (SFNR) on the use of Gadolinium-Based Contrast agents (GBCAs) and related MRI protocols in Neuroradiology.
    Lersy F; Boulouis G; Clément O; Desal H; Anxionnat R; Berge J; Boutet C; Kazémi A; Pyatigorskaya N; Lecler A; Saleme S; Edjlali-Goujon M; Kerleroux B; Ben Salem D; Kremer S; Cotton F
    J Neuroradiol; 2020 Nov; 47(6):441-449. PubMed ID: 32565280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pictorial review on abdominal applications of ferumoxytol in MR imaging.
    Kordbacheh H; Baliyan V; Parakh A; Wojtkiewicz GR; Hedgire S; Harisinghani MG
    Abdom Radiol (NY); 2019 Oct; 44(10):3273-3284. PubMed ID: 31378828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents.
    Layne KA; Dargan PI; Archer JRH; Wood DM
    Br J Clin Pharmacol; 2018 Nov; 84(11):2522-2534. PubMed ID: 30032482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
    Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
    Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
    Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
    J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical aspects of MRI signal change quantification after gadolinium-based contrast agents' administration.
    Ramalho J; Ramalho M; AlObaidy M; Semelka RC
    Magn Reson Imaging; 2016 Dec; 34(10):1355-1358. PubMed ID: 27693606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated guidelines for intravenous contrast use for CT and MRI.
    Huynh K; Baghdanian AH; Baghdanian AA; Sun DS; Kolli KP; Zagoria RJ
    Emerg Radiol; 2020 Apr; 27(2):115-126. PubMed ID: 31925592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary?
    Maloney E; Stanescu AL; Perez FA; Iyer RS; Otto RK; Leary S; Steuten L; Phipps AI; Shaw DWW
    Pediatr Radiol; 2018 Sep; 48(10):1472-1484. PubMed ID: 29789890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do we need gadolinium-based contrast medium for brain magnetic resonance imaging in children?
    Dünger D; Krause M; Gräfe D; Merkenschlager A; Roth C; Sorge I
    Pediatr Radiol; 2018 Jun; 48(6):858-864. PubMed ID: 29623352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of magnetic resonance contrast media.
    Runge VM
    Top Magn Reson Imaging; 2001 Aug; 12(4):309-14. PubMed ID: 11687717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-Trimester Exposure to Gadolinium-based Contrast Agents: A Utilization Study of 4.6 Million U.S. Pregnancies.
    Bird ST; Gelperin K; Sahin L; Bleich KB; Fazio-Eynullayeva E; Woods C; Radden E; Greene P; McCloskey C; Johnson T; Shinde M; Krefting I
    Radiology; 2019 Oct; 293(1):193-200. PubMed ID: 31429682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention Concerns About MR Studies Using Gadolinium-Based Contrast Agents.
    Barker PB; Lin DDM; Mahesh M
    J Am Coll Radiol; 2018 Jun; 15(6):934-936. PubMed ID: 29661521
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contrast agents in MRT. Substance, effects, pharmacology and validity].
    Reimer P; Vosshenrich R
    Radiologe; 2004 Mar; 44(3):273-83. PubMed ID: 15287365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can diffusion weighting replace gadolinium enhancement in magnetic resonance enterography for inflammatory bowel disease in children?
    Khachab F; Loundou A; Roman C; Colavolpe N; Aschero A; Bourlière-Najean B; Daidj N; Desvignes C; Pico H; Gorincour G; Auquier P; Petit P
    Pediatr Radiol; 2018 Sep; 48(10):1432-1440. PubMed ID: 29982955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
    Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
    Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Safety Issues Related to the Use of Gadolinium-based Contrast Agents.
    Pinter NK; Klein JP; Mechtler LL
    Continuum (Minneap Minn); 2016 Oct; 22(5, Neuroimaging):1678-1684. PubMed ID: 27740994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium-based contrast agents in children.
    Rozenfeld MN; Podberesky DJ
    Pediatr Radiol; 2018 Aug; 48(9):1188-1196. PubMed ID: 30078039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.